Evidence map›Paper›PMID 11826310›Full record

ArticleThe Plant cell2002

Reevaluation of the effects of brefeldin A on plant cells using tobacco Bright Yellow 2 cells expressing Golgi-targeted green fluorescent protein and COPI antisera.

Christophe Ritzenthaler, Andreas Nebenführ, Ali Movafeghi, Christiane Stussi-Garaud, Leila Behnia, Peter Pimpl, L Andrew Staehelin, David G Robinson

Open access · bronzeAbstract read
In one paragraph

Article in The Plant cell, 2002. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 149 papers.

0numbers the graph read from it
0cells of the map it votes in
149citing papers in PubMed
8.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

149 citing papers in PubMed, 339 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Trafficking and localization of Golgi-residentFrontiers in plant science · 2025
    Review
  6. Article
  7. Article
  8. Article
  9. Characterization of the smallbioRxiv : the preprint server for biology · 2024
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Phytotoxic compounds from endophytic fungi.Applied microbiology and biotechnology · 2022
    Review
  15. Review
  16. Review
  17. On the nature of the plant ER exit sites.Frontiers in plant science · 2022
    Article
  18. Review
  19. The Golgi Apparatus and its Next-Door Neighbors.Frontiers in cell and developmental biology · 2022
    Review
  20. Article

89 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 3 countries.

Christophe RitzenthalerInstitut de Biologie Moléculaire des Plantes, 67084 Strasbourg Cedex, France. christophe.ritzenthaler@ibmp-ulp.u.strasbg.fr
Andreas Nebenführ
Ali Movafeghi
Christiane Stussi-Garaud
Leila Behnia
Peter Pimpl
L Andrew Staehelin
David G Robinson
University of Göttingen · DEInstitut de Biologie Moléculaire des Plantes · FRUniversity of Colorado Boulder · US

Funding

STRUCTURE/MECHANISM OF ALPHA-KETO ACID DEPENDENT ENZYMESF32GM018639 · NIGMS · UNIVERSITY OF MINNESOTA TWIN CITIES · PI HEGG, ERIC L. · 1997 to 1998
–
NIGMS NIH HHS F32 GM018639NIGMS NIH HHS GM 18639
6 · The paper itself

Abstract

Brefeldin A (BFA) causes a block in the secretory system of eukaryotic cells by inhibiting vesicle formation at the Golgi apparatus. Although this toxin has been used in many studies, its effects on plant cells are still shrouded in controversy. We have reinvestigated the early responses of plant cells to BFA with novel tools, namely, tobacco Bright Yellow 2 (BY-2) suspension-cultured cells expressing an in vivo green fluorescent protein-Golgi marker, electron microscopy of high-pressure frozen/freeze-substituted cells, and antisera against Atgamma-COP, a component of COPI coats, and AtArf1, the GTPase necessary for COPI coat assembly. The first effect of 10 microg/mL BFA on BY-2 cells was to induce in <5 min the complete loss of vesicle-forming Atgamma-COP from Golgi cisternae. During the subsequent 15 to 20 min, this block in Golgi-based vesicle formation led to a series of sequential changes in Golgi architecture, the loss of distinct Golgi stacks, and the formation of an endoplasmic reticulum (ER)-Golgi hybrid compartment with stacked domains. These secondary effects appear to depend in part on stabilizing intercisternal filaments and include the continued maturation of cis- and medial cisternae into trans-Golgi cisternae, as predicted by the cisternal progression model, the shedding of trans-Golgi network cisternae, the fusion of individual Golgi cisternae with the ER, and the formation of large ER-Golgi hybrid stacks. Prolonged exposure of the BY-2 cells to BFA led to the transformation of the ER-Golgi hybrid compartment into a sponge-like structure that does not resemble normal ER. Thus, although the initial effects of BFA on plant cells are the same as those described for mammalian cells, the secondary and tertiary effects have drastically different morphological manifestations. These results indicate that, despite a number of similarities in the trafficking machinery with other eukaryotes, there are fundamental differences in the functional architecture and properties of the plant Golgi apparatus that are the cause for the unique responses of the plant secretory pathway to BFA.

Indexed as

Coatomer ProteinADP-Ribosylation Factor 1alpha-MannosidaseBiomarkersBrefeldin ACarrier ProteinsCell CompartmentationCells, CulturedCoat Protein Complex IEndoplasmic ReticulumFluorescent Antibody TechniqueGolgi ApparatusGreen Fluorescent ProteinsGTP PhosphohydrolasesIntracellular MembranesLuminescent ProteinsADP-Ribosylation Factor 1alpha-MannosidaseBiomarkersBrefeldin ACarrier ProteinsCoatomer ProteinCoat Protein Complex IGreen Fluorescent ProteinsGTP PhosphohydrolasesLuminescent ProteinsMannosidasesNon-programmatic

Identifiers

PMID11826310
PMCPMC150562
OpenAlexW2139646081

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.